查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年 DNA 定序市場預測：按產品、技術、用途、最終用戶和地區進行的全球分析
市場調查報告書
商品編碼
1372033

2030 年 DNA 定序市場預測：按產品、技術、用途、最終用戶和地區進行的全球分析

DNA Sequencing Market Forecasts to 2030 - Global Analysis By Product (Consumables, Instruments and Services), Technology (Next-Generation, Sequencing, Third Generation DNA Sequencing and Other Technologies), Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球 DNA 定序市場規模將達到 125 億美元，預計在預測期內將以 19.1% 的年複合成長率成長，到 2030 年將達到 425 億美元。

DNA 定序是一種使用廣泛的平行性來確定不同 DNA 鏈序列的過程。與微陣列和其他遺傳分析技術相比，DNA 定序的優點包括成本低、準確度高、速度快，即使輸入樣本量少也能得到可靠的結果。 DNA 定序的用途包括生物標記鑒定、腫瘤學研究、個體化醫療保健和法醫學。

據國家人類基因組研究所稱，持續的技術創新將導致 2021 年 8 月每個基因組的 NGS 成本為 562 美元，每兆鹼基為 0.006 美元。

基因組定序需求不斷成長

DNA 定序產業對基因組定序的需求量很大，因為它徹底改變了各個領域。此外，由於基因診斷、個人化醫療和癌症研究中對基因組定序的需求，臨床應用也不斷增加。此外，隨著基因組學不斷揭示潛在的疾病機制和潛在的治療方法，對基因組定序的需求預計會增加。這將加速 DNA 定序儀的新產品開發和市場開拓。

高成本

DNA 定序技術的高成本是市場的主要障礙。這些成本包括設備、消耗品和資料處理，使得定序配合措施通常在經濟上造成負擔。此外，定序計畫需要研究機構、臨床實驗室和醫療機構提供大量資金，而高昂的成本限制了尖端定序技術的取得，特別是在資源有限的環境中，並可能阻礙普及。這阻礙了市場的擴張。

DNA定序技術的進步

DNA 定序技術的發展徹底改變了基因組研究和臨床應用。此外，Illumina和Oxford Nanopore等公司的次世代定序（NGS）技術使高通量定序成為可能。此外，這些發展使得大規模基因組研究變得更加經濟實惠，並加快了資料收集速度。單分子定序和長讀長技術提高了 DNA 序列的準確性，使得分析複雜的基因組區域變得更容易。此外，它允許研究人員和臨床醫生在從農村地區到臨床設施的各種環境中進行定序活動，從而提高了基因組學的可及性和有效性。因此，這些要素是市場擴張的主要驅動力。

與隱私和資料分析相關的風險

DNA 定序市場一直受到隱私問題的阻礙。隨著基因檢測的使用增加，人們和組織對敏感基因資料的安全性和潛在濫用提出了擔憂。此外，這阻礙了人們參與基因研究和與醫療保健專業人員共用資訊，從而減緩了基因組學研究和治療應用的發展。此外，現代定序技術會產生大量資料，造成巨大的計算和資料分析障礙，阻礙有效的解釋和利用。

COVID-19 的影響

DNA 定序市場受到了 COVID-19 爆發的負面影響。疫情擾亂了供應鏈，限制了實驗室的使用，並給醫療機構造成了財務限制，從而影響了測序計劃和非大流行項目的研究經費。儘管有這些挑戰，大流行加速了定序在感染疾病研究中的引入，並逐漸限制了市場擴張。

預計消耗品領域在預測期內將是最大的

由於文庫建構各個階段（包括 DNA 片段化、富集、接頭連接、擴增和品管）的試劑和試劑盒廣泛可用，消耗品部分預計將佔據最大佔有率。它還包括用於樣品製備和分析的消耗品、流通池、引子、緩衝液和定序試劑。消耗品對於定序工作流程至關重要，因為它們可確保 DNA 序列的準確性和有效性。因此，消耗品產業為製造商提供了重要且穩定的收入來源，對於基因組學研究、臨床診斷和個人化醫療的進步至關重要。

次世代定序領域預計在預測期內年複合成長率最高

預計次世代定序領域將在預測期內出現良好的成長。 NGS 因其能夠以實惠的價格產生高品質的序列資料而成為主流定序方法。此外，NGS 已被證明比傳統定序技術更準確，使其適合癌症檢測和基因組研究等用途。此外，稱為次世代定序儀定序儀（NGS）系統的大規模平行定序儀可以在短時間內產生大量資料。因此，次世代定序儀技術憑藉其優越的準確性和檢測能力，有望獲得更大的市場佔有率。

比最大的地區

由於該地區經濟體的積極參與，亞太地區在預測期內獲得了最大的市場佔有率。此外，該地區許多國家啟動了大規模的基因組學計劃和研究計劃。鼓勵基因組在醫療保健中應用的重要舉措的例子包括日本的日本基因組醫學計劃和中國的精準醫學計劃。此外，政府資助以及與大企業的合作也支持該領域的創新。亞太地區龐大的人口為基因檢測和個人化醫療創造了龐大的市場。因此，該地區正在成為擴大基因組研究和 DNA 定序領域的焦點。

複合年複合成長率最高的地區：

預計歐洲在預測期內的年複合成長率最高。該地區受益於充滿活力的科學界、受人尊敬的研究機構以及促進基因組學研究創造力和金融投資的友好法規環境。此外，歐洲國家對醫療保健的大量投資增加了對個人化醫療、遺傳診斷和藥物基因組學中基因組應用的需求。此外，國際合作鼓勵大規模基因組學配合措施，加劇該地區的競爭。因此，歐洲的全民健保體係有利於將基因組資料涵蓋臨床實踐並刺激市場擴張。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球DNA 定序市場：依產品

  • 消耗品
  • 樂器
  • 服務

第6章 全球DNA 定序市場：依技術分類

  • 下一代定序
  • 第三代DNA定序
  • 其他技術

第7章 全球DNA 定序市場：依應用分類

  • 腫瘤學
  • 臨床調查
  • 法醫學和農業基因組學
  • 人類白血球抗原 (HLA) 分型
  • 生殖健康
  • 其他用途

第8章 全球DNA 定序市場：依最終用途

  • 學術研究
  • 臨床調查
  • 生物技術和製藥公司
  • 醫院和診所
  • 其他最終用戶

第9章 全球DNA 定序市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Agilent Technologies Inc.
  • Pacific Biosciences of California Inc.
  • Hamilton Thorne Biosciences
  • Bio-Rad Laboratories Inc.
  • Danaher Corporation
  • Hoffmann-La Roche Ltd
  • Illumina Inc.
  • Merck KGaA
  • Qiagen
  • PerkinElmer Inc.
  • Macrogen Inc.
  • Myriad Genetics Inc.
  • Eurofins Scientific
Product Code: SMRC24089

According to Stratistics MRC, the Global DNA Sequencing Market is accounted for $12.5 billion in 2023 and is expected to reach $42.5 billion by 2030 growing at a CAGR of 19.1% during the forecast period. DNA sequencing is a procedure that uses extensive parallelization to sequence different DNA strands. The advantages of DNA sequencing over microarray and other genetic analysis techniques include cheaper cost, higher accuracy and speed, and reliable results even with small sample input, applications for DNA sequencing include the identification of biomarkers, oncology research, individualized healthcare, forensics, and others.

According to National Human Genome Research Institute, due to continuous innovations, the cost of NGS per genome is USD 562, and the cost of NGS per megabase is USD 0.006 in August 2021.

Market Dynamics:

Driver:

Rising demand in genome sequencing

Genome sequencing is in greater demand in the DNA sequencing industry due to its transformational effects across a number of fields. Additionally, a rise in clinical applications is being caused by the necessity of genome sequencing in genetic diagnostics, customized medicine, and cancer research. Furthermore, the need for genome sequencing is anticipated to increase as genomics continues to shed light on the mechanisms underlying disease and potential treatments. Thus, this will encourage new product development and market expansion for DNA sequencing.

Restraint:

High cost

The high cost of DNA sequencing technologies is a key market obstacle. Equipment, consumables, and data processing are included in these costs, which frequently make sequencing efforts financially burdensome. Additionally, sequencing programs require huge amounts of cash from research institutions, clinical laboratories, and healthcare facilities, particularly in environments with limited resources, high expenses can restrict access to cutting-edge sequencing techniques and deter widespread adoption. Therefore, hampers the market expansion.

Opportunity:

Technological Advancements in DNA Sequencing

Genomic research and clinical applications have undergone a revolution due to technological developments in DNA sequencing. Additionally, high-throughput sequencing is made possible by next-generation sequencing (NGS) technologies from companies like Illumina and Oxford Nanopore. Moreover, because of the developments, large-scale genomic studies it has become more affordable, and data gathering has been speed up. The accuracy of DNA sequencing has increased because of single-molecule sequencing and long-read technologies, which also make it easier to analyze complex genomic areas. Furthermore, this has increased the accessibility and effect of genomics by enabling researchers and clinicians to conduct sequencing activities in a variety of contexts, from rural locations to clinical facilities. Therefore, these factors significantly have driven the market expansion.

Threat:

Risks associated with privacy and data analysis

The market for DNA sequencing has been hampered by privacy issues, as the use of genetic testing increases, people and organizations express concern about the security and potential abuse of highly sensitive genetic data. Additionally, this has made people hesitant to take part in genetic research and share information with healthcare professionals, which has slowed the development of genomics research and therapeutic applications. Furthermore, modern sequencing technologies create enormous amounts of data, which poses substantial computing and data analytic obstacles and hampers effective interpretation and utilization.

COVID-19 Impact

The market for DNA sequencing was negatively impacted by the COVID-19 epidemic. The pandemic impacted sequencing initiatives and research funding for non-pandemic projects by disrupting the supply chain, limiting laboratory access, and creating financial restrictions in healthcare institutions. Despite these challenges, the pandemic accelerated the adoption of sequencing for the research of infectious diseases, which gradually restrained market expansion.

The consumables segment is expected to be the largest during the forecast period

The consumables segment is estimated to hold the largest share, due to the widespread availability of reagents and kits for all library construction phases, including DNA fragmentation, enrichment, adapter ligation, amplification, and quality control. Additionally, this includes consumables used for sample preparation and analysis, flow cells, primers, buffers, and sequencing reagents. Consumables are essential to the sequencing workflow because they guarantee the precision and effectiveness of DNA sequencing. Therefore, the consumables industry provides manufacturers with a crucial and consistent source of income and is essential to the advancement of genomics research, clinical diagnostics, and customized medicine.

The next-generation sequencing segment is expected to have the highest CAGR during the forecast period

The next-generation sequencing segment is anticipated to have lucrative growth during the forecast period, due to its capacity to produce high-quality sequence data at affordable prices, NGS has become the predominant sequencing methodology. Furthermore, NGS has been shown to be more accurate than conventional sequencing techniques, making it appropriate for uses like cancer detection and genomics research. Moreover, massively parallel sequencers called next-generation sequencing (NGS) systems can produce a lot of data in a short amount of time. Therefore, due to its excellent accuracy and detection capacities, next-generation sequencing technology is anticipated to gain a greater market share.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to the active participation of the region's economies. Additionally, many nations in the region have started large-scale genomics initiatives and research plans. Examples of significant initiatives encouraging genomics applications in healthcare include Japan's "Japanese Genomic Medicine Program" and China's "Precision Medicine Initiative". Furthermore, governmental funding and partnerships with business titans are also encouraging innovation in the sector. The enormous population of the Asia-Pacific area creates a sizable market for genetic testing and tailored medicine. Thus, as a result, the area is gradually becoming a focus for genomics research and the expansion of the DNA sequencing sector.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. The area benefits from a vibrant scientific community, esteemed research institutions, and a friendly regulatory environment that promotes creativity and financial investment in genomics research. Additionally, the demand for genomic applications in personalized medicine, genetic diagnostics, and pharmacogenomics has increased as a result of significant investments made in healthcare in European nations. Furthermore, large-scale genomics initiatives are encouraged by international cooperation, which raises the region's competitiveness. Therefore, the universal healthcare systems in Europe make it easier to incorporate genomic data into clinical practice, which stimulates market expansion.

Key players in the market:

Some of the key players in the DNA Sequencing Market include: Agilent Technologies Inc., Pacific Biosciences of California Inc., Hamilton Thorne Biosciences, Bio-Rad Laboratories Inc., Danaher Corporation, Hoffmann-La Roche Ltd, Illumina Inc., Merck KGaA, Qiagen, PerkinElmer Inc., Macrogen Inc., Myriad Genetics Inc. and Eurofins Scientific.

Key Developments:

In March 2023, llumina Inc. a global leader in DNA sequencing and array-based technologies, announced that its first product based on its novel Illumina Complete Long Read technology is now available to order.

In September 2022, Illumina, Inc. announced the launch of the NovaSeq™ X Series (NovaSeq X and NovaSeq X Plus), new production-scale sequencers that will push the limits of what is possible with genomic medicine, enabling faster, more powerful, and more sustainable sequencing.

In January 2019, NRGene and Macrogen Corp announced the launch of a joint sequencing-based genotyping service, ArrayMAGIC, at the Plant and Animal Genome (PAG) conference in San Diego.

Products Covered:

  • Consumables
  • Instruments
  • Services

Technologies Covered:

  • Next-Generation Sequencing
  • Third Generation DNA Sequencing
  • Other Technologies

Applications Covered:

  • Oncology
  • Clinical Investigation
  • Forensics & Agrigenomics
  • Human Leukocyte Antigen (HLA) Typing
  • Reproductive Health
  • Other Applications

End Users Covered:

  • Academic Research
  • Clinical Research
  • Biotechnology & Pharmaceutical Companies
  • Hospitals & Clinics
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 Application Analysis
  • 3.9 End User Analysis
  • 3.10 Emerging Markets
  • 3.11 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global DNA Sequencing Market, By Product

  • 5.1 Introduction
  • 5.2 Consumables
  • 5.3 Instruments
  • 5.4 Services

6 Global DNA Sequencing Market, By Technology

  • 6.1 Introduction
  • 6.2 Next-Generation Sequencing
  • 6.3 Third Generation DNA Sequencing
  • 6.4 Other Technologies

7 Global DNA Sequencing Market, By Application

  • 7.1 Introduction
  • 7.2 Oncology
  • 7.3 Clinical Investigation
  • 7.4 Forensics & Agrigenomics
  • 7.5 Human Leukocyte Antigen (HLA) Typing
  • 7.6 Reproductive Health
  • 7.7 Other Applications

8 Global DNA Sequencing Market, By End Use

  • 8.1 Introduction
  • 8.2 Academic Research
  • 8.3 Clinical Research
  • 8.4 Biotechnology & Pharmaceutical Companies
  • 8.5 Hospitals & Clinics
  • 8.6 Other End Users

9 Global DNA Sequencing Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Agilent Technologies Inc.
  • 11.2 Pacific Biosciences of California Inc.
  • 11.3 Hamilton Thorne Biosciences
  • 11.4 Bio-Rad Laboratories Inc.
  • 11.5 Danaher Corporation
  • 11.6 Hoffmann-La Roche Ltd
  • 11.7 Illumina Inc.
  • 11.8 Merck KGaA
  • 11.9 Qiagen
  • 11.10 PerkinElmer Inc.
  • 11.11 Macrogen Inc.
  • 11.12 Myriad Genetics Inc.
  • 11.13 Eurofins Scientific

List of Tables

  • Table 1 Global DNA Sequencing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 4 Global DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 5 Global DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 6 Global DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 7 Global DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 8 Global DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
  • Table 9 Global DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 10 Global DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 11 Global DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 12 Global DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
  • Table 13 Global DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
  • Table 14 Global DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
  • Table 15 Global DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
  • Table 16 Global DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Global DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
  • Table 18 Global DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
  • Table 19 Global DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 20 Global DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
  • Table 21 Global DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 22 Global DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 23 North America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
  • Table 24 North America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 25 North America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 26 North America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 27 North America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 28 North America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 29 North America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 30 North America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
  • Table 31 North America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 32 North America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 33 North America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 34 North America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
  • Table 35 North America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
  • Table 36 North America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
  • Table 37 North America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
  • Table 38 North America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 39 North America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
  • Table 40 North America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
  • Table 41 North America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 42 North America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
  • Table 43 North America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 44 North America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 45 Europe DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
  • Table 46 Europe DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 47 Europe DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 48 Europe DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 49 Europe DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 50 Europe DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 51 Europe DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 52 Europe DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
  • Table 53 Europe DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 54 Europe DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 55 Europe DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 56 Europe DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
  • Table 57 Europe DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
  • Table 58 Europe DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
  • Table 59 Europe DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
  • Table 60 Europe DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 61 Europe DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
  • Table 62 Europe DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
  • Table 63 Europe DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 64 Europe DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
  • Table 65 Europe DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 66 Europe DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 67 South America DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
  • Table 68 South America DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 69 South America DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 70 South America DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 71 South America DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 72 South America DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 73 South America DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 74 South America DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
  • Table 75 South America DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 76 South America DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 77 South America DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 78 South America DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
  • Table 79 South America DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
  • Table 80 South America DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
  • Table 81 South America DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
  • Table 82 South America DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 83 South America DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
  • Table 84 South America DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
  • Table 85 South America DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 86 South America DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
  • Table 87 South America DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 88 South America DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 89 Middle East & Africa DNA Sequencing Market Outlook, By Country (2021-2030) ($MN)
  • Table 90 Middle East & Africa DNA Sequencing Market Outlook, By Product (2021-2030) ($MN)
  • Table 91 Middle East & Africa DNA Sequencing Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 92 Middle East & Africa DNA Sequencing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 93 Middle East & Africa DNA Sequencing Market Outlook, By Services (2021-2030) ($MN)
  • Table 94 Middle East & Africa DNA Sequencing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 95 Middle East & Africa DNA Sequencing Market Outlook, By Next-Generation Sequencing (2021-2030) ($MN)
  • Table 96 Middle East & Africa DNA Sequencing Market Outlook, By Third Generation DNA Sequencing (2021-2030) ($MN)
  • Table 97 Middle East & Africa DNA Sequencing Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 98 Middle East & Africa DNA Sequencing Market Outlook, By Application (2021-2030) ($MN)
  • Table 99 Middle East & Africa DNA Sequencing Market Outlook, By Oncology (2021-2030) ($MN)
  • Table 100 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Investigation (2021-2030) ($MN)
  • Table 101 Middle East & Africa DNA Sequencing Market Outlook, By Forensics & Agrigenomics (2021-2030) ($MN)
  • Table 102 Middle East & Africa DNA Sequencing Market Outlook, By Human Leukocyte Antigen (HLA) Typing (2021-2030) ($MN)
  • Table 103 Middle East & Africa DNA Sequencing Market Outlook, By Reproductive Health (2021-2030) ($MN)
  • Table 104 Middle East & Africa DNA Sequencing Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 105 Middle East & Africa DNA Sequencing Market Outlook, By End Use (2021-2030) ($MN)
  • Table 106 Middle East & Africa DNA Sequencing Market Outlook, By Academic Research (2021-2030) ($MN)
  • Table 107 Middle East & Africa DNA Sequencing Market Outlook, By Clinical Research (2021-2030) ($MN)
  • Table 108 Middle East & Africa DNA Sequencing Market Outlook, By Biotechnology & Pharmaceutical Companies (2021-2030) ($MN)
  • Table 109 Middle East & Africa DNA Sequencing Market Outlook, By Hospitals & Clinics (2021-2030) ($MN)
  • Table 110 Middle East & Africa DNA Sequencing Market Outlook, By Other End Users (2021-2030) ($MN)